| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +19% |
| 3Y CAGR | +35% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +58% |
| 3Y CAGR | +71% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,316.10 -9.50 (0.41%) | 17,671.58 | 26.06 | 5.24 | ||
PfizerPFIZER | ₹3,633.30 -54.50 (1.48%) | 16,867.42 | 22.94 | 4.01 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,410.50 +46.00 (0.72%) | 15,918.38 | 93.84 | 18.24 | ||
Natco PharmaNATCOPHARM | ₹784.65 +2.25 (0.29%) | 15,350.14 | 13.41 | 1.46 |